Safety Shot Inc. Secures $10.6 Million Through Registered Direct Offering and Private Placement

Reuters
25 Jul
<a href="https://laohu8.com/S/SHOT">Safety Shot Inc</a>. Secures $10.6 Million Through Registered Direct Offering and Private Placement

Safety Shot Inc., a wellness and dietary supplement company, has announced the pricing of a registered direct offering with an institutional investor, raising approximately $10.6 million. This offering involves the sale of 28,648,648 shares of common stock at $0.37 per share. Alongside this, the company has issued warrants in a concurrent private placement, allowing for the purchase of up to 57,297,296 additional shares at the same price, exercisable immediately and expiring in five years. Dominari Securities, LLC acted as the exclusive placement agent. This financing is expected to bolster Safety Shot's financial position, aiding in the integration following its recent merger with Yerbaé and supporting expanded operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Safety Shot Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-020871), on July 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10